SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 224 filers reported holding SAGE THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.71 and the average weighting 0.1%.
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HARBOR CAPITAL ADVISORS, INC. | 21,053 | $989,912 | 0.20% |
EASTERLY INVESTMENT PARTNERS LLC | 42,800 | $2,012,456 | 0.18% |
Inspire Advisors, LLC | 19,553 | $919,381 | 0.18% |
Cavalier Investments, LLC | 9,679 | $455,107 | 0.17% |
Virtus ETF Advisers LLC | 5,920 | $278,358 | 0.16% |
PLATINUM INVESTMENT MANAGEMENT LTD | 91,933 | $4,322,690 | 0.15% |
PAX Financial Group, LLC | 14,131 | $664,440 | 0.15% |
PINNACLE ASSOCIATES LTD | 181,988 | $8,557,076 | 0.15% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 20,360 | $957,327 | 0.13% |
LORD, ABBETT & CO. LLC | 827,577 | $38,913 | 0.13% |
FOX RUN MANAGEMENT, L.L.C. | 9,606 | $451,674 | 0.13% |
Edgestream Partners, L.P. | 27,349 | $1,285,950 | 0.12% |
HUSSMAN STRATEGIC ADVISORS, INC. | 12,400 | $583,048 | 0.11% |
Empowered Funds, LLC | 57,153 | $2,687,334 | 0.09% |
EA Series Trust | 57,153 | $2,687,334 | 0.09% |
TWINBEECH CAPITAL LP | 95,417 | $4,486,507 | 0.09% |
Verition Fund Management LLC | 139,105 | $6,540,717 | 0.09% |
Ergoteles LLC | 35,309 | $1,660,229 | 0.08% |
Inspire Investing, LLC | 13,880 | $652,622 | 0.08% |
Candriam S.C.A. | 227,000 | $10,673,540 | 0.08% |
External links
This page lists SAGE THERAPEUTICS INC's shareholders in Q2 2023. To view SAGE THERAPEUTICS INC's shareholder history, click here.